Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2024-09-11 Report Publication Anno…
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
关于2024年半年度报告的更正公告
Report Publication Announcement Classification · 95% confidence The document is titled as a correction announcement for the 2024 half-year report (半年度报告) of Shanghai MicroPort EP MedTech Co., Ltd. It specifically states that it is a correction to the previously published 2024 half-year report and clarifies that the correction does not materially affect the financial status or operating results. The document is short (1083 characters) and mainly serves to notify investors of the correction and direct them to the corrected report on the exchange website. It does not contain the full financial statements or substantive financial data itself, but rather an announcement about the correction to the interim report. According to the 'MENU VS MEAL' rule, such a short document announcing a correction to a report is classified as a Report Publication Announcement (RPA), not the interim report (IR) itself.
2024-09-11 Chinese
关于首次公开发行战略配售限售股份上市流通公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the listing and circulation of restricted shares from the company's initial public offering (IPO). It details the number of shares becoming freely tradable after a lock-up period, the date of circulation, shareholder commitments, and verification by an intermediary institution. There is no financial statement, earnings data, or management discussion. The document is regulatory in nature, informing the market about the change in share circulation status. It fits best under the category of Regulatory Filings (RNS) as it is a formal disclosure about share circulation and compliance with regulatory requirements, not a financial report or capital raising update.
2024-08-22 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司首次公开发行限售股上市流通的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion from Huatai United Securities regarding the listing and circulation of restricted shares from the company's initial public offering (IPO) on the STAR Market. It discusses the type and quantity of restricted shares becoming tradable, the compliance with relevant laws and regulations, and confirms that the shareholders have fulfilled their commitments. The document is a formal verification or audit opinion related to the IPO share circulation, not a full annual or interim financial report, earnings release, or management discussion. It is not a simple announcement but a detailed verification opinion by the sponsor and underwriter. This fits the category of an Audit Report / Information (AR), as it is a standalone audit/verification report related to regulatory compliance and share issuance. The document length is 2835 characters, which is relatively short but contains substantive verification content rather than just an announcement or certification. Therefore, the best classification is AR with high confidence. FY 2024
2024-08-22 Chinese
关于使用自有资金、外汇支付募投项目部分款项并以募集资金等额置换的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shanghai MicroPort EP MedTech Co., Ltd. regarding the use of self-owned funds and foreign exchange to pay for part of the fundraising investment projects and the equivalent replacement with raised funds. It details the background, reasons, procedures, and approvals related to the use and replacement of funds raised from an IPO. The document includes references to regulatory approvals, board and supervisory committee meetings, and compliance with relevant regulatory guidelines. The content is focused on capital management and financing activities related to the company's fundraising projects, rather than presenting financial statements or earnings data. The document length is 3923 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under the category of Capital/Financing Update (CAP).
2024-08-21 Chinese
关于变更会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's accounting firm from one auditor to another. It details the reasons for the change, information about the new auditor, communication with the previous auditor, and the approval process by the audit committee and board of directors. It does not contain any financial statements, audit reports, or detailed financial data itself. The document is relatively short (3905 characters) and serves as a formal notification of the auditor change, which is a regulatory announcement rather than the audit report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about auditor change.
2024-08-21 Chinese
关于使用暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shanghai MicroPort EP MedTech Co., Ltd. regarding the use of temporarily idle raised funds for cash management. It details the board and supervisory committee meetings approving the use of up to 750 million RMB of idle raised funds for cash management, including investment product types, risk control measures, and compliance with regulatory requirements. The document references regulatory approvals, prior announcements, and includes opinions from the supervisory board and sponsor. The document length is 3649 characters, which is relatively short and primarily serves as a formal announcement of a corporate financing activity related to the use of raised funds, rather than a full financial report or audit. It does not contain financial statements or detailed financial analysis. Therefore, it fits best under Capital/Financing Update (CAP) as it updates on the company's financing activities and use of capital raised.
2024-08-21 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.